These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 907504)

  • 1. [Morphology of immune destruction of the erythrocytes in fetuses and newborn infants].
    Gurevich PS
    Arkh Patol; 1977; 39(6):19-24. PubMed ID: 907504
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The role of the fetal immune system in the pathogenesis of RhD-hemolytic disease of newborns.
    Gurevich P; Erina S; Gershon S; Zusman I
    Hum Antibodies; 1997; 8(2):76-89. PubMed ID: 9289392
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The management of severe erythroblastosis fetalis by fetal transfusion: survival of transfused adult erythrocytes in the fetus.
    Pattison N; Roberts A
    Obstet Gynecol; 1989 Dec; 74(6):901-4. PubMed ID: 2586955
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Destruction of IgG anti-A sensitized erythrocytes by mononuclear leucocytes from normal and ABO haemolytic disease affected infants.
    Romano EL; Rossi Devivo ML; Soyano A; Linares J
    Clin Exp Immunol; 1984 Feb; 55(2):451-8. PubMed ID: 6538121
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Phagocytosis and erythroblastosis. I. Modification of the neonatal response by promethazine hydrochloride.
    Gusdon JP; Caudle MR; Herbst GA; Iannuzzi NP
    Am J Obstet Gynecol; 1976 May; 125(2):224-6. PubMed ID: 944534
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The impact of intrauterine transfusions on morphological picture of red cells in Rh incompatibility.
    Lozińska D
    Arch Immunol Ther Exp (Warsz); 1987; 35(6):775-9. PubMed ID: 2468318
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mechanisms of hemolysis.
    Zipursky A
    Mead Johnson Symp Perinat Dev Med; 1982; (19):17-24. PubMed ID: 6821465
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Immunohematological study in newborn infants with erythroblastosis fetalis transfused in utero.
    Ancora G; Dallacasa P; Gavella B; Calderoni L; Nucci S; Belletti D; Sorci NA; Conte R; Salvioli GP
    Acta Biomed Ateneo Parmense; 1997; 68 Suppl 1():99-102. PubMed ID: 10021725
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fetal macrocytosis in association with chromosomal abnormalities.
    Fisk NM; Tannirandorn Y; Santolaya J; Nicolini U; Letsky EA; Rodeck CH
    Obstet Gynecol; 1989 Oct; 74(4):611-6. PubMed ID: 2477774
    [TBL] [Abstract][Full Text] [Related]  

  • 10. IgG-mediated immunosuppression is not dependent on erythrocyte clearance or immunological evasion: implications for the mechanism of action of anti-D in the prevention of haemolytic disease of the newborn?
    Brinc D; Le-Tien H; Crow AR; Freedman J; Lazarus AH
    Br J Haematol; 2007 Oct; 139(2):275-9. PubMed ID: 17897303
    [TBL] [Abstract][Full Text] [Related]  

  • 11. In vitro erythrophagocytosis by cultured macrophages stimulated with extraneous substances and those isolated from the blood, spleen and bone marrow of Boran and N'Dama cattle infected with Trypanosoma congolense and Trypanosoma vivax.
    Taiwo VO; Anosa VO
    Onderstepoort J Vet Res; 2000 Dec; 67(4):273-87. PubMed ID: 11206395
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The immune destruction of red cells.
    Engelfriet CP
    Transfus Med; 1992 Mar; 2(1):1-6. PubMed ID: 1308459
    [No Abstract]   [Full Text] [Related]  

  • 13. RhD haemolytic disease of the fetus and the newborn.
    Urbaniak SJ; Greiss MA
    Blood Rev; 2000 Mar; 14(1):44-61. PubMed ID: 10805260
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody dependent cell mediated cytotoxicity and erythrophagocytosis assays in Rh haemolytic disease of the newborn.
    Patil JS; Gupte SC
    Ceylon Med J; 1996 Jun; 41(2):46-50. PubMed ID: 8771942
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Titers and hemolytic late effects of rhesus antibodies in exchange transfusion in newborn infants with hemolytic anemia due to the rhesus factor].
    Ruckstuhl J
    Helv Paediatr Acta; 1970 Jul; 25(3):258-72. PubMed ID: 4996413
    [No Abstract]   [Full Text] [Related]  

  • 16. Fetal and maternal red cell immune adherence (RCIA) receptors.
    Siegel I; Gleicher N
    Prog Clin Biol Res; 1981; 70():115-20. PubMed ID: 7198258
    [No Abstract]   [Full Text] [Related]  

  • 17. The mechanism of the action of anti-D in the prophylaxis of Rhesus sensitization.
    Hummel K
    Ann Immunol Hung; 1972; 16(0):160-73. PubMed ID: 4213456
    [No Abstract]   [Full Text] [Related]  

  • 18. Use of the erythrophagocytosis assay for predicting the clinical consequences of immune blood cell destruction.
    Biondi CS; Cotorruelo CM; Ensinck A; Racca LL; Racca AL
    Clin Lab; 2004; 50(5-6):265-70. PubMed ID: 15209434
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Complement receptor type three-dependent degradation of opsonized erythrocytes by mouse macrophages.
    Rothlein R; Springer TA
    J Immunol; 1985 Oct; 135(4):2668-72. PubMed ID: 3897377
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Erythrophagocytosis in hemolytic disease of the newborn.
    Radhakrishnan K; Tan C; Gallo J
    Am J Hematol; 2008 Aug; 83(8):679. PubMed ID: 17696209
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.